Katharine E. Spink
Director de Operaciones en Dark Horse Consulting Group, Inc. .
Cargos activos de Katharine E. Spink
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Dark Horse Consulting Group, Inc.
 Dark Horse Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Dark Horse Consulting Group, Inc. develops cell and gene therapy products. The firm offers process development, custom device development, project and program management, financing and diligence, manufacturing support and preclinical development services. The company was founded by Anthony H. Davies in 2014 and is headquartered in Campbell, CA. | Director de Operaciones | 01/01/2018 | - |
Historial de carrera de Katharine E. Spink
Antiguos cargos conocidos de Katharine E. Spink.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ASTERIAS BIOTHERAPEUTICS INC | Director de Operaciones | 01/03/2013 | 19/01/2018 |
| Cardiovascular Disease Foundation, Inc. | Corporate Officer/Principal | 01/01/2003 | 01/01/2008 |
| GERON CORPORATION | Director de Operaciones | 01/12/2003 | - |
Formación de Katharine E. Spink.
| Rice University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Chief Operating Officer | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GERON CORPORATION | Health Technology |
| Empresas privadas | 3 |
|---|---|
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
| Cardiovascular Disease Foundation, Inc. | |
Dark Horse Consulting Group, Inc.
Dark Horse Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Dark Horse Consulting Group, Inc. develops cell and gene therapy products. The firm offers process development, custom device development, project and program management, financing and diligence, manufacturing support and preclinical development services. The company was founded by Anthony H. Davies in 2014 and is headquartered in Campbell, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Katharine E. Spink
- Experiencia
